News NICE delivers more good news for cervical cancer patients Hundreds of women with locally advanced cervical cancer are to be offered MSD's Keytruda on the NHS in England, thanks to new NICE guidance.
News NICE says Libtayo can be used for advanced cervical cancer New NICE guidance means that around 90 UK women with cervical cancer should be eligible for treatment with Regeneron's Libtayo each year.
News Pushy NHS chatbots 'can put patients off screening' Amid the push to digitise the UK health service, a study has sounded a note of caution about entrusting important patient appointments to chatbots.
News NICE changes stance on Genmab's cervical cancer drug After saying it couldn't recommend Genmab's cervical cancer therapy Tivdak for use by the NHS, reimbursement authority NICE has had a change of heart.
News NICE says no to Genmab cervical cancer therapy Genmab's recently approved therapy for relapsed cervical cancer has been turned down for NHS use in initial NICE guidance.
News Gates-backed game aims to raise HPV awareness in Africa Psyon is running a pilot study of a game that aims to raise awareness of HPV infection and vaccination in sub-Saharan Africa.
News Ipsen charts $1.75bn course for Kartos acquisition Ipsen has agreed to buy cancer biotech Kartos Therapeutics for $450m upfront, adding a late-stage drug in the challenging MDM2 inhibitor class.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.